We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 558

Two important updates from CFIA

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 25 2015

Earlier this month, CFIA asked industry associations to circulate a letter advising of CFIA’s new process for issuing public warnings for food

Consultation on new consumer health products framework ends Friday, Feb. 27, 2015

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 25 2015

Health Canada released details on a proposed new regulatory framework for consumer health products (“CHPs”) that will include non-prescription drugs

Bill C-17: protecting Canadians from Unsafe Drugs Act (Vanessa's Law) is now law

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 25 2015

The Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) (“Vanessa’s Law”) received Royal Assent on Nov. 6, 2014 and is now law. Vanessa’s Law

British Columbia Court of Appeal overturns certification of pharmaceutical class action

  • Stikeman Elliott LLP
  • -
  • Canada
  • -
  • February 20 2015

In a decision released January 22, 2015, the B.C. Court of Appeal unanimously overturned an order certifying a class proceeding against the

Files exhibited, fines unlimited: health industry risks under the new Bill C-17

  • Cassels Brock & Blackwell LLP
  • -
  • Canada
  • -
  • February 17 2015

The Minister of Health and Health Canada have bulked up with new powers over the holidays, and the medical products community needs to take notice

Keeping you up-to-date on consumer product regulation: what’s new with the Canada Consumer Product Safety Act?

  • Cassels Brock & Blackwell LLP
  • -
  • Canada
  • -
  • February 17 2015

As part of Health Canada’s stated ongoing commitment to transparency, it has announced that it will be publishing the following summary reports on

Charlton in charge: BC Court of Appeal overturns pharmaceutical class action certification due to plaintiff’s failure to provide workable causation methodology

  • Cassels Brock & Blackwell LLP
  • -
  • Canada
  • -
  • February 17 2015

Canadian courts may be taking a firmer stance against certification in pharmaceutical class actions. The recent decision of the British Columbia

Amended Maple Products Regulations in force

  • Miller Thomson LLP
  • -
  • Canada
  • -
  • February 5 2015

Grading and quality standards for maple syrup prepared in federally registered establishments in Canada are regulated by the Maple Products

Made in Canada, but sold south of the border: a cautionary tale for supply chain participants

  • Osler Hoskin & Harcourt LLP
  • -
  • Canada, USA
  • -
  • February 5 2015

In Canada, liability for a defective product can attach to all participants in a supply chain to varying degrees, including retailers, suppliers

Targeting the Canadian consumer - an important primer on the advertising and marketing laws in Canada

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 29 2015

Traditional methods of marketing advertisements, give-aways, promotions and contests can still be an effective way to sell a product or service